Results 171 to 180 of about 4,918 (294)
Understanding barriers to healthcare services utilization among women in Mauritania: a socio-anthropological analysis. [PDF]
Bost C +3 more
europepmc +1 more source
A Modified Arthroscopic Trans‐Septal Approach via the Figure‐to‐4 Position of the Knee
Abstract Standard anterior and posterior portals offer limited access to pathologies in the posterior compartment of the knee. The trans‐septal portal facilitates comprehensive visualization and instrumentation in the posterolateral and posteromedial compartments.
Ning Sheng +4 more
wiley +1 more source
Justice, Disability, and Law: A Neurological and Ethical Assessment of Multiple Sclerosis in Turkey. [PDF]
Yılmaz F +3 more
europepmc +1 more source
Zuranolone: A case study in (regulatory) rush to judgement?
Abstract Sage, in collaboration with Biogen, submitted a new drug approval for zuranolone for postpartum depression (PPD) and major depressive disorder (MDD) in December 2022. In August 2023, the US Food and Drug Administration granted approval for PPD but denied approval for MDD.
Lisa Cosgrove +4 more
wiley +1 more source
Perioperative Antidepressant Use Increases the Risk of Opioid Abuse After Total Joint Arthroplasty. [PDF]
Mirahmadi A +5 more
europepmc +1 more source
THE PROBLEM OF ABUSE OF SUBSTANTIVE AND PROCEDURAL RIGHTS: CONCEPT AND FEATURES OF ABUSE OF RIGHT
openaire +2 more sources
Aim This report presents a series of 16 patients who were admitted to the emergency department following confirmed intake of the potent synthetic cannabinoid ADB‐CHMINACA. Methods The cases are drawn from a prospective observational study following the recreational use of synthetic cannabinoids.
Maren Hermanns‐Clausen +7 more
wiley +1 more source
A Child-Centered Framework for Determining Mental Distress Severity and Liability: Evidence from Chinese Judicial Practice. [PDF]
Xue Q, Yu D, Zhang Z.
europepmc +1 more source
Aim Recovering dysbiosis may improve atopic dermatitis (AD) symptoms. XZ.700 is a recombinant chimeric endolysin that specifically targets Staphylococcus aureus and could be a new treatment option for patients with AD. The aim of this first‐in‐human study was to evaluate the safety, tolerability and efficacy of topical XZ.700 and explore the ...
Laura W. J. van der Meulen +13 more
wiley +1 more source

